Sources | Names Used |
---|---|
CTRPv2 | YL54 |
PharmacoGx | YL54 |
Database | Identifier |
---|---|
Smiles: | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCCC=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-463C8.4 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | CH507-9B2.1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
mRNA | UTS2 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
mRNA | TMEM89 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | TMEM63C | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | ICOSLG | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
mRNA | MYCL | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | RAPGEF5 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
mRNA | SIT1 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
mRNA | BLK | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-07 |